| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tharimmune, Inc. (THAR) has 9 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. THAR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 226.0K | - | - | |
| Other | 190.0K | - | - | |
| 10% | 190.0K | - | - | |
| Dir | 82.5K | - | - | |
| Dir | 67.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Gravitas Capital LP | Executive Chairman | Buy | 337,838 | $1.48 | $500,000.24 | +85.6% | |
| Jun 20, 2025 | Appajosyula Sireesh | Chief Executive Officer | Buy | 61,496 | $1.48 | $90,972.68 | +91.0% | |
| Jun 20, 2025 | Parikh Sanam | Director | Buy | 1,000 | $1.45 | $1,450.00 | +129.9% | |
| May 15, 2025 | Parikh Sanam | Director | Buy | 770 | $1.30 | $1,001.00 | New | |
| Dec 19, 2024 | Milby Randy | CEO | Buy | 4,600 | $2.12 | $9,752.00 | +35.6% | |
| Nov 13, 2024 | Appajosyula Sireesh | Chief Operating Officer | Buy | 5,000 | $2.02 | $10,096.00 | +86.8% | |
| Oct 8, 2024 | Milby Randy | CEO | Buy | 2,500 | $2.09 | $5,221.04 | +7.2% | |
| Oct 8, 2024 | Appajosyula Sireesh | Chief Operating Officer | Buy | 5,000 | $1.93 | $9,650.00 | +44.0% | |
| Dec 15, 2023 | Milby Randy | CEO | Buy | 29,000 | $0.50 | $14,587.00 | +22.7% | |
| Nov 30, 2023 | Milby Randy | CEO | Buy | 10,000 | $1.00 | $10,000.00 | +8.5% |